Understanding the distinction between temporary medication-related gastric slowing and true gastroparesis is essential for safe, effective diabetes management
In the Phase III LIBERTY-UC and LIBERTY-CD studies, Zymfentra elicited higher rates of clinical remission than placebo in patients with moderate-to-severe UC and CD, respectively, following induction with intravenous infliximab
Our inclusive pricing covers all pre-operative laboratory panels, advanced operating room access, professional fees for the surgical and anesthesia teams, and all post-operative follow-up appointments
Hartmans Five-Type Obesity Framework Excess intake relative to expenditure, without a significant underlying biological driver
Parameswaran, Narayanan, and Sonika Patial